- SRPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $78.5 million.
- SRPT has traded 277,459 shares today.
- SRPT is down 6.4% today.
- SRPT was up 60.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SRPT with the Ticky from Trade-Ideas. See the FREE profile for SRPT NOW at Trade-Ideas More details on SRPT: Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. Currently there are 7 analysts that rate Sarepta Therapeutics a buy, no analysts rate it a sell, and 9 rate it a hold. The average volume for Sarepta Therapeutics has been 895,600 shares per day over the past 30 days. Sarepta has a market cap of $660.6 million and is part of the health care sector and drugs industry. The stock has a beta of 1.20 and a short float of 32.2% with 4.27 days to cover. Shares are up 13.2% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.